Financial News

ViroPharma's $4.2B deal is nothing to sneeze at

Long before its focus on rare diseases fueled a $4.2 billion merger deal with Shire Pharmaceuticals, ViroPharma had a much simpler target for its first product...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback